Abstract
Extracorporeal life support (ECLS) is a direct extension of cardiopulmonary bypass technology used for providing supports to patient with cardiorespiratory failure despite maximum conventional therapy. The blood drained from an outflow cannula gets oxygenated and decarboxylated before it returns through an inflow cannula.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McDonald JV, Green TP, Steinhorn RH. The role of the centrifugal pump in hemolysis during neonatal extracorporeal support. ASAIO J. 1997;43(1):35–8.
Kawahito K, Nosé Y. Hemolysis in different centrifugal pumps. Artif Organs. 1997;21(4):323–6.
Steinhorn RH, Isham-Schopf B, Smith C, Green TP. Hemolysis during long-term extracorporeal membrane oxygenation. J Pediatr. 1989;115(4):625–30.
Lehle K, Lubnow M, Philipp A, et al. Prevalence of hemolysis and metabolic acidosis in patients with circulatory failure supported with extracorporeal life support: a marker for survival? Eur J Heart Fail. 2017;19(Suppl 2):110–6.
Tamari Y, Lee-Sensiba K, Leonard EF, Parnell V, Tortolani AJ. The effects of pressure and flow on hemolysis caused by Bio-Medicus centrifugal pumps and roller pumps. Guidelines for choosing a blood pump. J Thorac Cardiovasc Surg. 1993;106(6):997–1007.
Mendler N, Podechtl F, Feil G, Hiltmann P, Sebening F. Seal-less centrifugal blood pump with magnetically suspended rotor: rot-a-flot. Artif Organs. 1995;19(7):620–4.
Lawson DS, Lawson AF, Walczak R, et al. North American neonatal extracorporeal membrane oxygenation (ECMO) devices and team roles: 2008 survey results of Extracorporeal Life Support Organization (ELSO) centers. J Extra Corpor Technol. 2008;40(3):166–74.
Tamari Y, Lee-Sensiba K, King S, Hall MH. An improved bladder for pump control during ECMO procedures. J Extra Corpor Technol. 1999;31(2):84–90.
Schaadt J. Fiber manufacturing, membrane classification, and winding technologies associated with membrane oxygenators. J Extra Corpor Technol. 1998;30(1):30–4.
Thiara AP, Hoel TN, Kristiansen F, Karlsen HM, Fiane AE, Svennevig JL. Evaluation of oxygenators and centrifugal pumps for long-term pediatric extracorporeal membrane oxygenation. Perfusion. 2007;22(5):323–6.
Eash HJ, Jones HM, Hattler BG, Federspiel WJ. Evaluation of plasma resistant hollow fiber membranes for artificial lungs. ASAIO J. 2004;50(5):491–7.
Horton S, Thuys C, Bennett M, Augustin S, Rosenberg M, Brizard C. Experience with the Jostra Rotaflow and QuadroxD oxygenator for ECMO. Perfusion. 2004;19(1):17–23.
Segers PA, Heida JF, de Vries I, Maas C, Boogaart AJ, Eilander S. Clinical evaluation of nine hollow-fibre membrane oxygenators. Perfusion. 2001;16(2):95–106.
Augustin S, Horton A, Butt W, Bennett M, Horton S. Centrifugal pump inlet pressure site affects measurement. Perfusion. 2010;25(5):313–20.
Peek GJ, Firmin RK. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J. 1999;45(4):250–63.
Bembea MM, Annich G, Rycus P, Oldenburg G, Berkowitz I, Pronovost P. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med. 2013;14(2):e77–84.
Uden DL, Payne NR, Kriesmer P, Cipolle RJ. Procedural variables which affect activated clotting time test results during extracorporeal membrane oxygenation therapy. Crit Care Med. 1989;17(10):1048–51.
Seay RE, Uden DL, Kriesmer PJ, Payne NR. Predictive performance of three methods of activated clotting time measurement in neonatal ECMO patients. ASAIO J. 1993;39(1):39–42.
Bosch YP, Ganushchak YM, de Jong DS. Comparison of ACT point-of-care measurements: repeatability and agreement. Perfusion. 2006;21(1):27–31.
Maul TM, Wolff EL, Kuch BA, Rosendorff A, Morell VO, Wearden PD. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2012;13(6):e363–71.
Chan AK, Black L, Ing C, Brandão LR, Williams S. Utility of aPTT in monitoring unfractionated heparin in children. Thromb Res. 2008;122(1):135–6.
Ignjatovic V, Furmedge J, Newall F, et al. Age-related differences in heparin response. Thromb Res. 2006;118(6):741–5.
Khaja WA, Bilen O, Lukner RB, Edwards R, Teruya J. Evaluation of heparin assay for coagulation management in newborns undergoing ECMO. Am J Clin Pathol. 2010;134(6):950–4.
Liveris A, Bello RA, Friedmann P, et al. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*. Pediatr Crit Care Med. 2014;15(2):e72–9.
Bembea MM, Schwartz JM, Shah N, et al. Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation. ASAIO J. 2013;59(1):63–8.
Irby K, Swearingen C, Byrnes J, Bryant J, Prodhan P, Fiser R. Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study. Pediatr Crit Care Med. 2014;15(4):e175–82.
Northrop MS, Sidonio RF, Phillips SE, et al. The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life. Pediatr Crit Care Med. 2015;16(1):66–74.
Kostousov V, Nguyen K, Hundalani SG, Teruya J. The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assay. Arch Pathol Lab Med. 2014;138(11):1503–6.
Alexander DC, Butt WW, Best JD, Donath SM, Monagle PT, Shekerdemian LS. Correlation of thromboelastography with standard tests of anticoagulation in paediatric patients receiving extracorporeal life support. Thromb Res. 2010;125(5):387–92.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Hu, Q. (2023). Equipment and Devices of Extracorporeal Life Support. In: Hei, F., Guan, Y., Yu, K. (eds) Extracorporeal life support. Springer, Singapore. https://doi.org/10.1007/978-981-19-9275-9_2
Download citation
DOI: https://doi.org/10.1007/978-981-19-9275-9_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-9274-2
Online ISBN: 978-981-19-9275-9
eBook Packages: MedicineMedicine (R0)